Literature DB >> 7159161

[Treatment of rickets caused by infantile cystinosis using 1 alpha-hydroxyvitamin D].

B Betend, P Chatelain, L David, R François.   

Abstract

Two unrelated girls presented with cystinotic rickets: bone lesions were severe in the first case despite high vitamin D intake, and moderate but significant in the second patient who received physiologic vitamin D prophylaxis since early life. At 56 and 13 months respectively, both patients were given 1 alpha hydroxyvitamin D, 0.5 to 1 microgram/d, with good to excellent results. These data suggest that: 1. Cystinotic bone lesions are to some extent dependent on renal 1 alpha hydroxylase deficiency; 2. 1 alpha OHD thus appears as an effective and appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7159161

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  5 in total

1.  Progressive destructive bone changes in patients with cystinosis.

Authors:  Maria Klusmann; William Van't Hoff; Fergal Monsell; Amaka C Offiah
Journal:  Skeletal Radiol       Date:  2013-09-28       Impact factor: 2.199

Review 2.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

3.  Chiari I Malformation in Nephropathic Cystinosis.

Authors:  Kavya I Rao; John Hesselink; Doris A Trauner
Journal:  J Pediatr       Date:  2015-08-08       Impact factor: 4.406

4.  Atypical manifestations of infantile-onset nephropathic cystinosis: a diagnostic challenge.

Authors:  Bobbity Deepthi; Sriram Krishnamurthy; Pediredla Karunakar; Gowrishankar Barathidasan; Thiagarajan Narayanasamy Rajavelu
Journal:  CEN Case Rep       Date:  2022-01-20

Review 5.  Cystinosis: a review.

Authors:  Mohamed A Elmonem; Koenraad R Veys; Neveen A Soliman; Maria van Dyck; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  Orphanet J Rare Dis       Date:  2016-04-22       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.